• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION, INC BD¿ SPINAL ANESTHESIA TRAY; ANESTHESIA CONDUCTION KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION, INC BD¿ SPINAL ANESTHESIA TRAY; ANESTHESIA CONDUCTION KIT Back to Search Results
Catalog Number 400866
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Insufficient Information (4580)
Event Date 01/05/2022
Event Type  malfunction  
Manufacturer Narrative
Date of event: unknown.Medical device expiration date: unknown.Initial reporter email address: (b)(6).A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown.
 
Event Description
It was reported that the anesthesia failed to administer while using the bd¿ spinal anesthesia tray.This event occurred 6 times.There was no report of patient impact.The following information was provided by the initial reporter: they have had six failed attempts at administering due to the bupivacaine/dextrose/marcaine vial being degraded.These six attempts were made by three different anesthesiologists.
 
Manufacturer Narrative
The following fields have been updated with corrected and/or additional information: multiple lot numbers: there were multiple lot numbers reported to be involved.The information for each lot number is as follows: d4.Medical device lot #: 0001424490, d4.Medical device expiration date: 07/13/2021, h4.Device manufacture date: 06/30/2022.D4.Medical device lot #: 0001426415, d4.Medical device expiration date: 07/28/2021, h4.Device manufacture date: 06/30/2022.
 
Event Description
It was reported that the anesthesia failed to administer while using the bd¿ spinal anesthesia tray.This event occurred 6 times.There was no report of patient impact.The following information was provided by the initial reporter: they have had six failed attempts at administering due to the bupivacaine/dextrose/marcaine vial being degraded.These six attempts were made by three different anesthesiologists.
 
Event Description
It was reported that the anesthesia failed to administer while using the bd¿ spinal anesthesia tray.This event occurred 6 times.There was no report of patient impact.The following information was provided by the initial reporter: they have had six failed attempts at administering due to the bupivacaine/dextrose/marcaine vial being degraded.These six attempts were made by three different anesthesiologists.
 
Manufacturer Narrative
The following fields were updated due to additional information: d9: device available for eval yes.D9: returned to manufacturer on: 03-mar-2020.H6: investigation summary three ampules sample were provided to our quality team for evaluation.The returned samples contained a clear and colorless solution free from visible particles.Ampules appeared clear with no discernible haze or particulate matter; therefore, the reported failure could not be verified.A review of the internal manufacturing device records and raw material history files for the reported lot numbers 0001426415 and 0001424490 was performed and no recorded quality problems or rejections related to this incident were found.Product undergoes inspections during manufacturing, no issues related to the reported incident were identified, all procedural and functional requirements for product release have been met.Based on the available information we are not able to identify a root cause at this time.H3 other text : see h10.
 
Manufacturer Narrative
Correction: the following fields have been corrected.B5: describe event or problem: it was reported that the anesthesia failed to administer while using the bd¿ spinal anesthesia tray.This event occurred 11 times.There was no report of patient impact.The following information was provided by the initial reporter: they have had five failed attempts at administering due to the bupivacaine/dextrose/marcaine vial being degraded from an lot 400866.They have had six failed attempts at administering due to the bupivacaine/dextrose/marcaine vial being degraded from an unknown lot.These attempts were made by three different anesthesiologists.H1: type of reportable events serious injury.
 
Event Description
It was reported that the anesthesia failed to administer while using the bd¿ spinal anesthesia tray.This event occurred 11 times.There was no report of patient impact.The following information was provided by the initial reporter: they have had five failed attempts at administering due to the bupivacaine/dextrose/marcaine vial being degraded from an lot 400866.They have had six failed attempts at administering due to the bupivacaine/dextrose/marcaine vial being degraded from an unknown lot.These attempts were made by three different anesthesiologists.
 
Event Description
It was reported that the anesthesia failed to administer while using the bd¿ spinal anesthesia tray.This event occurred 11 times.There was no report of patient impact.The following information was provided by the initial reporter: they have had five failed attempts at administering due to the bupivacaine/dextrose/marcaine vial being degraded from an lot 400866.They have had six failed attempts at administering due to the bupivacaine/dextrose/marcaine vial being degraded from an unknown lot.These attempts were made by three different anesthesiologists.
 
Manufacturer Narrative
The following fields were corrected: b.1adverse type: the reported issue is both an adverse event and product problem.B.2 event attributed to: required intervention.C.1.Name, manufacturer/compounder, strength: bupivacaine hcl (0.75%) with dextrose (8.25%), 2 ml (marcaine).G5.Is combination product? yes.H5: imdrf annex f grid: f12.
 
Manufacturer Narrative
B.1 adverse type: product problem; b.2 event attributed: na; h1: type of reportable events: malfunction; h5: imdrf annex f grid: f24.No information was received on medical intervention or patient impact.This supplemental is to correct the event back to malfunction as no serious injury was reported.H3 other text : see h10.
 
Event Description
It was reported that the anesthesia failed to administer while using the bd¿ spinal anesthesia tray.This event occurred 6 times.There was no report of patient impact.The following information was provided by the initial reporter: they have had six failed attempts at administering due to the bupivacaine/dextrose/marcaine vial being degraded.These six attempts were made by three different anesthesiologists.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD¿ SPINAL ANESTHESIA TRAY
Type of Device
ANESTHESIA CONDUCTION KIT
Manufacturer (Section D)
CAREFUSION, INC
400 east foster rd
mannford OK 74044
Manufacturer (Section G)
CAREFUSION, INC
400 east foster rd
mannford OK 74044
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key13334653
MDR Text Key285699716
Report Number1625685-2022-00021
Device Sequence Number1
Product Code CAZ
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 06/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number400866
Device Lot NumberSEE H.10.
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/05/2022
Initial Date FDA Received01/24/2022
Supplement Dates Manufacturer Received01/05/2022
04/13/2022
02/03/2023
02/03/2023
06/05/2023
Supplement Dates FDA Received01/28/2022
04/21/2022
02/04/2023
02/17/2023
06/06/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-